BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  FDA

  Houston’s Hope BioSciences Highlights Texas’ Hotbed Status

  Texas is quickly becoming a hotbed of biopharmaceutical activities, with Houston being one of the two top cities in the state that is leading the way.

  April 28, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  Global Roundup: UK Expands Life Sciences Ecosystem with Formation of We Are Pioneering Group

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

  April 28, 2021

   · 

  10 min read

   · 

  Alex Keown
• 

  Drug Development

  Companies Betting Oral Vaccines, Therapies Will Boost Fight Against COVID-19

  Researchers are continuing to develop next-generation therapeutics and oral vaccines that could overcome some vaccine hesitancy. Here are some of the top producers.

  April 28, 2021

   · 

  4 min read

   · 

  Alex Keown
• 

  Business

  Biotech Tilts at the Tipping Point of Gender Equality

  A recent report by Deerfield Management Company revealed an unsettling but unsurprising truth: There is a significant gender gap on the boards of venture-backed healthcare companies.

  April 28, 2021

   · 

  5 min read

   · 

  Heather McKenzie
• 

  Policy

  FDA Issues CRL for Protalix and Chiesi’s Fabry Disease Drug

  The companies indicated they are studying the CRL to determine the best way to understand the problems and what course of action they might take.

  April 28, 2021

   · 

  2 min read

   · 

  Mark Terry
• 

  Job Trends

  Novartis CEO Says Remote Work Hybrid Should Mean Access to New Talent Pools

  Novartis AG Chief Executive Officer Vas Narasimhan believes that the hybrid of remote and on-site office work is the future.

  April 28, 2021

   · 

  3 min read

   · 

  Ava Barnes
• 

  Business

  Developing ‘Antennae’ for Drug Regulation and Policy: A Conversation with Geoffrey Levitt

  Levitt has practiced law for over 20 years in the FDA regulatory space. Previously chief regulatory counsel for Pfizer Inc., Levitt has had extensive experience working with an interdisciplinary team of scientists, executives and lawyers to push a candidate to market.

  April 28, 2021

   · 

  5 min read

   · 

  Maggie Chen
• 

  Biotech Bay

  Preparing a Pandemic Plan for Whatever Comes Our Way Next

  According to Teo, the definition of the next pandemic depends a lot on one’s perspective.

  April 28, 2021

   · 

  7 min read

   · 

  Heather McKenzie
• 

  FDA

  Takeda Closes in on Potential Approval for NSCLC Drug, Mobocertinib

  Takeda’s non-small cell lung cancer treatment Mobocertinib is leading closer to regulatory approval after the U.S. Food and Drug Administration granted priority review to the New Drug Application.

  April 28, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Genetown

  Less than 18 Months After Launch, Ohana Biosciences Closes Its Doors

  Launched in January 2020 by Flagship Pioneering, Ohana was being dubbed a “first-in-category reproductive health company” focused on the industry’s first sperm biology platform.

  April 28, 2021

   · 

  3 min read

   · 

  Mark Terry